Novo Nordisk overtakes LVMH as Europe’s most valuable company

The Danish pharmaceutical group Novo Nordisk replaces the French luxury manufacturer LVMH as the most valuable group in Europe. The company benefits from funds that are intended to help against obesity, a widespread disease.

Es is a changing of the guard at the top of the most valuable companies in Europe. Novo Nordisk, a Danish medical group founded a hundred years ago, was Europe’s most valuable company for the first time in September. The company is in good company. For years, Shell was the most valuable group in Europe, followed by the food group Nestlé from Switzerland and the French luxury group LVMH. In the meantime, ASML and Roche were also the most valuable companies on the stock exchange for a short time.

The fact that Novo Nordisk is now the most valuable listed company is primarily due to its own strength: The Danes owe their soaring to the strong demand for their products against diabetes and obesity. The older a society is and the more unhealthy it eats, the higher the probability of this happening. And Europe is currently suffering from a veritable obesity epidemic, as the World Health Organization (WHO) recently stated.